The health-related quality of life and survival of small-cell lung cancer patients: Results of a companion study to CALGB 9033

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Quality of Life Research

• Publication date

  2002-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1015257121369PMID 12074261
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small Cell Lung Cancer: Limited Disease

  2004cited by this paper
• Quality of life scores: An independent prognostic variable in a general population of cancer patients receiving chemotherapy

  2004cited by this paper
• Management of small-cell lung cancer.

  2002cited by this paper
• Influence of psychological response on survival in breast cancer: a population-based cohort study.

  1999cited by this paper
• Management of small cell lung cancer.

  1999cited by this paper
• Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute.

  1997cited by this paper
• SAS System for Mixed Models

  1996cited by this paper
• Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

  1996cited by this paper
• Analyzing survival data from clinical trials and observational studies

  1996cited by this paper
• A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial.

  1996cited by this paper
• Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group fo

  1995cited by this paper
• Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.

  1995cited by this paper
• Assessment of 'quality of life' using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer.

  1995cited by this paper
• Analysing Survival Data from Clinical Trials and Observational Studies; E. Marubini & M. G. Valsecchi Published by John Wiley & Sons 414 pages ISBN 0-971-93987-0.

  1995cited by this paper
• Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.

  1995cited by this paper
• Neurological and cognitive impairment in long-term survivors of small cell lung cancer.

  1994cited by this paper
• Prognostic factors for survival in terminal lung cancer patients

  1994cited by this paper
• A randomized trial of two etoposide schedules in small-cell lung cancer: the influence of pharmacokinetics on efficacy and toxicity.

  1994cited by this paper
• Quality of life in lung cancer surgical adjuvant trials.

  1994cited by this paper
• Weekly carboplatin and VM-26 for elderly patients with small-cell lung cancer.

  1994cited by this paper
• The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

  1993cited by this paper
• Women with lung cancer: impact on quality of life

  1993cited by this paper
• A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.

  1993influential reference
• A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer.

  1993cited by this paper
• A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Party.

  1993influential reference
• “Fatigue and malaise” as a quality-of-life indicator in small-cell lung cancer patients

  1993cited by this paper
• Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

  1993cited by this paper
• Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile.

  1992cited by this paper
• Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience.

  1991cited by this paper
• A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial.

  1991cited by this paper
• Quality of life assessment. An independent prognostic variable for survival in lung cancer

  1991cited by this paper
• Prospective study of etoposide scheduling in combination chemotherapy for limited disease small cell lung carcinoma.

  1991cited by this paper
• The MOS social support survey.

  1991cited by this paper
• Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.

  1990influential reference
• Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research.

  1990cited by this paper
• Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial.

  1990cited by this paper
• Phase II trial of daily oral VP-16 in refractory small cell lung cancer: a Hoosier Oncology Group study.

  1990influential reference
• Chronic daily administration of oral etoposide--a phase I trial.

  1989cited by this paper
• A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.

  1989cited by this paper
• Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients' subjective experience of disease and psychosocial well-being.

  1989cited by this paper
• Development of a Brief Screening Instrument for Detecting Depressive Disorders

  1988cited by this paper
• Regression modelling strategies for improved prognostic prediction.

  1984cited by this paper
• Analysis of a pathology review of patients with lung tumors.

  1981cited by this paper
• VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.

  1978cited by this paper
• The diverse effects of histopathology on manifestations and outcome of lung cancer.

  1974cited by this paper

• PAINLESS: protocol for a triple-blinded randomized sham-controlled multicenter trial of home-based transcranial electrical stimulation for pain management in patients with cancer

  2025cites this paper
• Depression increases cancer mortality by 23-83%: a meta-analysis of 65 studies across five major cancer types.

  2025cites this paper
• Opposing inflammatory biomarker responses to sleep disruption in cancer patients before and during oncological therapy

  2022cites this paper
• Sleep During Oncological Treatment – A Systematic Review and Meta-Analysis of Associations With Treatment Response, Time to Progression and Survival

  2022influential citation
• A Systematic Literature Review and Head-to-Head Comparison of Social Support and Social Constraint in Relation to the Psychological Functioning of Cancer Survivors.

  2019cites this paper
• THE ASSOCIATION BETWEEN DISTRESS AND BOTH SOCIAL SUPPORT AND SOCIAL CONSTRAINT IN RECENTLY DIAGNOSED CANCER SURVIVORS: A DAILY ASSESSMENT STUDY

  2018cites this paper
• Evaluating methodological quality of Prognostic models Including Patient-reported HeAlth outcomes iN oncologY (EPIPHANY): a systematic review protocol

  2018cites this paper
• Qualitative Study of Psychosocial Needs for Individuals with Lung Cancer

  2017cites this paper
• Integrating tobacco treatment into thoracic oncology settings: Lessons learned

  2016cites this paper
• Lung Cancer Stigma: Associated Variables and Coping Strategies

  2016cites this paper
• Comparison of generic and lung cancer-specific quality of life instruments for predictive ability of survival in patients with advanced lung cancer

  2016cites this paper
• Patient-reported outcomes as end points and outcome indicators in solid tumours

  2015cites this paper
• Social support and quality of life among lung cancer patients: a systematic review

  2013cites this paper
• [National consensus of diagnosis and treatment of non-small cell lung cancer].

  2013cites this paper
• Relationship between the depression status of patients with resectable non-small cell lung cancer and their family members in China.

  2013cites this paper
• Adults surviving lung cancer two or more years: A systematic review.

  2012cites this paper
• Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.

  2012cites this paper
• Adults surviving lung cancer two or more years: A systematic review

  2012cites this paper
• ealth-related quality of life in patients with lung cancer : Validation of the exican-Spanish version and association with prognosis of the EORTC QLQ-LC 13 uestionnaire scar

  2012cites this paper
• Prognostic Factors in Lung Cancer

  2011cites this paper
• A Smoking Cessation Intervention for Thoracic Surgery and Oncology Clinics: A Pilot Trial

  2011cites this paper
• 肺癌化疗前后生活质量及抑郁情绪改变分析

  2011cites this paper
• Health and Quality of Life Outcomes

  2010cites this paper
• Health related quality of life in NCI-sponsored cancer treatment trials.

  2010cites this paper
• Associations of social networks with cancer mortality: a meta-analysis.

  2010cites this paper
• Depression and cancer mortality: a meta-analysis

  2010influential citation
• Home enteral tube feeding - from patients’, relatives’ and nurses’ perspectives

  2010cites this paper
• Depression as a predictor of disease progression and mortality in cancer patients

  2009cites this paper
• Social support and cancer progression: a systematic review.

  2009cites this paper
• Is Quality of Life Data Predictive of the Survival in Cancer Patients? A Rapid and Systematic Review of the Literature

  2009cites this paper
• The prognostic significance of patient-reported outcomes in cancer clinical trials.

  2008cites this paper
• Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer.

  2008cites this paper
• Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation

  2008cites this paper
• Patient education level as a predictor of survival in lung cancer clinical trials.

  2008cites this paper
• Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.

  2007cites this paper
• Psychometric validation of the Patient Symptom Assessment in Lung Cancer instrument for small cell lung cancer

  2007cites this paper
• Quality of life in lung cancer patients: impact of baseline clinical profile and respiratory status.

  2007cites this paper
• Social support and survival in patients with acute myeloid leukaemia

  2006cites this paper
• Quality of life in newly diagnosed patients with lung cancer in a developing country: is it important?

  2006cites this paper
• Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: report from the Cancer and Leukemia Group B.

  2006cites this paper
• The benefits of frequent positive affect: does happiness lead to success?

  2005cites this paper
• Quality of life.

  2004cites this paper
• Prognostic factors.

  2004cites this paper
• Clinical Presentation of Lung Cancer

  2004cites this paper
• Outcomes Research in Cancer Clinical Trial Cooperative Groups: The RTOG Model

  2004cites this paper
• Quality-of-life considerations in patients with advanced lung cancer: effect of topotecan on symptom palliation and quality of life.

  2004cites this paper
• Beyond Money

  2004cites this paper
• Prognostic factors of small cell lung cancer.

  2004cites this paper
• Baseline FACT-G score is a predictor of survival for advanced lung cancer

  2004cites this paper